Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Cell and Developmental Biology|January 21, 2026
The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibitionFabio Giuntini, Jonathan R Whitfield, Daniel Massó-Vallés, et al.
Nature Reviews. Cancer|June 24, 2017
Drugging the 'undruggable' cancer targetsChi V Dang, E Premkumar Reddy, Kevan M Shokat, et al.
Signal Transduction and Targeted Therapy|August 20, 2024
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancerSílvia Casacuberta-Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, et al.
Oncogene|August 29, 2003
c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosisSatoshi Kanazawa, Laura Soucek, Gerard Evan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2024
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugateSandra Bibbò, Emily Capone, Giulio Lovato, et al.
Analytical Biochemistry|November 5, 2003
High-throughput methods to detect dimerization of Bcl-2 family proteinsJonathan Whitfield, Kokichi Harada, Catherine Bardelle, et al.
Frontiers in Immunology|February 9, 2026
MYC at the tumor-immune interface: mechanisms of immune escape and immunotherapy resistanceÍñigo González-Larreategui, Manrique Valdés-Bango Martín, Sílvia Casacuberta-Serra, et al.
Cancer Research|June 18, 2002
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosisLaura Soucek, Richard Jucker, Laura Panacchia, et al.
Plos One|March 29, 2017
Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimersLoïka Maltais, Martin Montagne, Mikaël Bédard, et al.
Pediatrics|March 4, 2003
Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infantsJonathan Whitfield, Twyala Smith, Heather Sollohub, et al.
Pageof 8